Ying Li
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Diabetes Treatment and Management, Adipose Tissue and Metabolism, Legal and Regulatory Analysis
Most-Cited Works
- → Role of AMP-activated protein kinase in mechanism of metformin action(2001)635 cited
- → Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy(2017)331 cited
- → Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality(2014)229 cited
- → ASIC1a regulates insular long-term depression and is required for the extinction of conditioned taste aversion(2016)61 cited
- → Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers(2004)58 cited
- → Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver(2019)41 cited
- → Homogeneous assays for adenosine 5′-monophosphate-activated protein kinase(2003)36 cited
- → Cytochrome P450 3A4-Mediated Oxidative Conversion of a Cyano to an Amide Group in the Metabolism of Pinacidil(2002)35 cited
- → Hit-to-Lead Optimization and Discovery of 5-((5-([1,1′-Biphenyl]-4-yl)-6-chloro-1 H -benzo[ d ]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein Kinase(2017)26 cited
- → Stability of Blood Biomarkers of Traumatic Brain Injury(2019)21 cited